Evidence map›Paper›PMID 33772152›Full record

SynthesisBritish journal of cancer2021

Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.

Amina Amadou, Heinz Freisling, Mazda Jenab, Konstantinos K Tsilidis, Antonia Trichopoulou, Paolo Boffetta, Bethany Van Guelpen, Olatz Mokoroa, Tom Wilsgaard, Frank Kee and 11 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in British journal of cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 3 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 3 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 11 countries.

Amina AmadouInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Heinz FreislingInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France. freislingh@iarc.fr.ORCID http://orcid.org/0000-0001-8648-4998
Mazda JenabInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Konstantinos K TsilidisDepartment of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
Antonia TrichopoulouHellenic Health Foundation, Athens, Greece.
Paolo BoffettaStony Brook Cancer Center, Stony Brook University, Stony Brook, NY, USA.
Bethany Van GuelpenDepartment of Radiation Sciences, Oncology Umeå University, Umeå, Sweden.
Olatz MokoroaPublic Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.
Tom WilsgaardDepartment of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Frank KeeInstitute for Health Sciences Risk and Inequality, Centre for Public Health, Belfast, UK.
Ben SchöttkerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID http://orcid.org/0000-0002-1217-4521
José M Ordóñez-MenaNuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Woodstock Road, Oxford, UK.
Satu MännistöDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
Stefan SöderbergDepartment of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
Roel C H VermeulenEnvironmental Epidemiology, Institute for Risk Assessment Sciences (IRAS), Utrecht University, Utrecht, the Netherlands.
J Ramón QuirósPublic Health Directorate, Asturias, Spain.
Linda M LiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Kari KuulasmaaDepartment of Public Health and Welfare, Finnish Institute for Health and Welfare (THL), Helsinki, Finland.ORCID http://orcid.org/0000-0003-2165-1411
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Isabelle RomieuInternational Agency for Research on Cancer (IARC/WHO), Nutrition and Metabolism Branch, Lyon, France.
Centre international de recherche sur le cancer · FRFinnish Institute for Health and Welfare · FIGerman Cancer Research Center · DENational Cancer Institute · USUmeå University · SEBiogipuzkoa Health Research Institute · ESCentre Léon Bérard · FRGobierno del Principado de Asturias · ESHellenic Health Foundation · GRStony Brook University · USUiT The Arctic University of Norway · NOUniversity of Ioannina · GRUniversity of Oxford · GBUtrecht University · NL

Funding

Prospective Studies of Diet and Cancer in the AARP CohortZIACP010196 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SINHA, RASHMI · 2009 to 2025
$21.0M
Medical Research Council G0601463Medical Research Council MR/K023241/1World Health Organization 001
6 · The paper itself

Abstract

backgroundWe investigated whether associations between prevalent diabetes and cancer risk are pertinent to older adults and whether associations differ across subgroups of age, body weight status or levels of physical activity.

methodsWe harmonised data from seven prospective cohort studies of older individuals in Europe and the United States participating in the CHANCES consortium. Cox proportional hazard regression was used to estimate the associations of prevalent diabetes with cancer risk (all cancers combined, and for colorectum, prostate and breast). We calculated summary risk estimates across cohorts using pooled analysis and random-effects meta-analysis.

resultsA total of 667,916 individuals were included with an overall median (P25-P75) age at recruitment of 62.3 (57-67) years. During a median follow-up time of 10.5 years, 114,404 total cancer cases were ascertained. Diabetes was not associated with the risk of all cancers combined (hazard ratio (HR) = 0.94; 95% confidence interval (CI): 0.86-1.04; I

conclusionsPrevalent diabetes was positively associated with colorectal cancer risk and inversely associated with prostate cancer risk in older Europeans and Americans.

Indexed as

AgedAged, 80 and overAgingBreast NeoplasmsCohort StudiesColorectal NeoplasmsDiabetes MellitusEuropeFemaleHumansMaleMiddle AgedNeoplasmsPrevalenceProstatic NeoplasmsRisk Factors

Identifiers

PMID33772152
PMCPMC8144608
OpenAlexW3136130740

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.